Table 2.
Descriptive and inferential statistics of the secondary outcomes measures.
| Before test | After test | Within-group effectsb | δ | |
|---|---|---|---|---|
| FM | ||||
| M1 + CIMT | 20 (16–24) | 29 (24–31) | −2.04 (0.01)∗ | −0.67c |
| PMC + CIMT | 21 (18–23) | 33 (29–35) | −2.86 (0.02)∗ | −0.82c |
| Sham + CIMT | 20 (18–22) | 24 (21–26) | −0.44 (0.01)∗ | −0.11 |
| Between-group effectsa | 1.98 (0.77) | 11.6 (0.02)∗ | ||
|
| ||||
| MAS | ||||
| M1 + CIMT | 17 (11–19) | 11 (9–14) | −1.94 (0.01)∗ | 0.61c |
| PMC + CIMT | 16 (12–18) | 7 (5–10) | −2.87 (0.02)∗ | 0.71c |
| Sham + CIMT | 18 (11–21) | 15 (12–18) | −1.16 (0.03)∗ | 0.09 |
| Between-group effectsa | 2.13 (0.82) | 15.2 (0.03)∗ | ||
|
| ||||
| BBT | ||||
| M1 + CIMT | 1 (1–3) | 3 (1–5) | −0.81 (0.73) | −0.14 |
| PMC + CIMT | 1 (1–3) | 7 (4–9) | −2.98 (0.02)∗ | −0.67c |
| Sham + CIMT | 1 (1–4) | 2 (1–4) | −0.31 (0.58) | −0.04 |
| Between-group effectsa | 1.44 (0.60) | 12.7 (0.01)∗ | ||
|
| ||||
| MRC | ||||
| M1 + CIMT | 4 (1–7) | 5 (1–7) | −0.61 (0.52) | −0.10 |
| PMC + CIMT | 3 (1–7) | 11 (8–14) | −3.01 (0.03)∗ | −0.87c |
| Sham + CIMT | 4 (2–7) | 6 (2–8) | −0.89 (0.80) | −0.06 |
| Between-group effectsa | 2.57 (0.97) | 13.1 (0.02)∗ | ||
Data are expressed as the median (interquartile range-IQR).
FM: Fugl-Meyer Assessment-Upper Extremity scale.
MAS: Modified Ashworth Scale.
BBT: Box and Block Test.
MRC: Medical Research Council scale.
δ: Cliff's delta score.
aKruskal-Wallis test (p value).
bWilcoxon test (p value).
cLarge effect size.
∗ p < 0.05.